A tumor-initiating CSC population in RCC has been defined by the expression of CD105, CD44, and CD73 cell surface markers [133], and TG2 was found to be necessary for maintenance of the CD105+/CD44+/CD73+ phenotype in metastatic Caki-1 RCC cell population [134]. The gene discussed is CD44; the disease is neoplasm.